← FDA DRUG APPROVALS

FDA ANDA · ANDA070707

DIAZEPAM

Sponsor: ACTAVIS ELIZABETH

APPLICATION
ANDA070707
TYPE
ANDA
ORIGINAL APPROVAL
1986-03-19
LATEST ACTION
2003-11-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DIAZEPAMDiscontinued
DIAZEPAM 10MG · TABLET · ORAL

Approval history

2003-11-20Labeling · Supplement 17AP
2002-10-11Manufacturing (CMC) · Supplement 15AP
2001-11-02Manufacturing (CMC) · Supplement 14AP
2000-10-25Manufacturing (CMC) · Supplement 12AP
2000-10-25Manufacturing (CMC) · Supplement 13AP
1999-11-04Manufacturing (CMC) · Supplement 11AP
1999-07-20Manufacturing (CMC) · Supplement 10AP
1996-01-18Manufacturing (CMC) · Supplement 9AP
1993-03-31Labeling · Supplement 8AP
1990-11-21Manufacturing (CMC) · Supplement 7AP
1989-03-27Manufacturing (CMC) · Supplement 5AP
1989-03-27Manufacturing (CMC) · Supplement 6AP
1988-06-07Labeling · Supplement 4AP
1988-01-21Manufacturing (CMC) · Supplement 2AP
1988-01-21Manufacturing (CMC) · Supplement 1AP
1986-03-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →